03:20 AM EDT, 10/15/2025 (MT Newswires) -- Andrew Cheng, Director, President and Chief Executive Officer, on October 10, 2025, sold 30,000 shares in Akero Therapeutics ( AKRO ) for $1,619,340. Following the Form 4 filing with the SEC, Cheng has control over a total of 526,114 common shares of the company, with 526,114 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000119312525239343/xslF345X05/ownership.xml